John D Kulman

This inventor holds 21 USPTO granted patents and 31 published patent applications, plus 2 CIPO patents and 11 EPO patents, primarily in Exosome Therapeutics. Top assignees: Bioverativ Therapeutics Inc., Codiak Biosciences, Inc., Lonza Sales Ag. Active years: 2018-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: John D Kulman. Retrieved from https://idiyas.com/inventor/john-d-kulman

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 21 (Patent Applications = 31)

% Patents Active = 100.0

CIPO Patents = 2 (Patent Applications = 7)

EPO Patents = 11 (Patent Applications = 29)

Average Co-Inventor Count = 3.8

ph-index = 5

Forward Citations = 83(Granted Patents)

Location History:

Belmont, MA (US) (2018 - 2024)
South Boston, MA (US) (2024)

Company Filing History:

10 out of 77

Bioverativ Therapeutics Inc.

patents

4 out of 14

Codiak Biosciences, Inc.

Crispr Therapeutics Ag

patents

6. 1 out of 834,601

Other

patents

Years Active: 2018-2026

Loading Chart...

Areas of Expertise:

Exosomes

Therapeutics

Factor VIII

Chimeric Proteins

Immuno-Oncology

Anti-Inflammatory

Purification

Membrane Proteins

ANGPTL3

Recombinant Proteins

Fusion Proteins

Therapeutic Applications

21 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12622876 - METHODS OF SUPPRESSING DELIVERY OF EXOSOMES TO LIVER AND SPLEEN (2026-05-12),

2. 12617839 - Factor VIII chimeric proteins and uses thereof (2026-05-05),

3. 12570691 - PURIFICATION OF CHIMERIC FVIII MOLECULES (2026-03-10),

4. 12331100 - Exosomes for immuno-oncology and anti-inflammatory therapy (2025-06-17),

5. 12257313 - Preparation of therapeutic exosomes using membrane proteins (2025-03-25),

6. 12158424 - Methods of measuring exosomes using intrinsic fluorescence (2024-12-03),

7. 12037616 - Methods and compositions for treating angiopoietin-like 3 (ANGPTL3) related conditions (2024-07-16),

8. 12030924 - Exosomes for immuno-oncology and anti-inflammatory therapy (2024-07-09),

9. 11685771 - Recombinant factor VIII proteins (2023-06-27),

10. 11679164 - Preparation of therapeutic exosomes using membrane proteins (2023-06-20),

11. 11192936 - Factor VIII chimeric proteins and uses thereof (2021-12-07),

12. 11091534 - Factor VIII complex with XTEN and von Willebrand Factor protein, and uses thereof (2021-08-17),

13. 10947269 - Purification of chimeric FVIII molecules (2021-03-16),

14. 10745680 - Factor IX fusion proteins and methods of making and using same (2020-08-18),

15. 10723782 - Exosomes for immuno-oncology and anti-inflammatory therapy (2020-07-28),

Title: John Kulman: Pioneering Inventor from Belmont, MA

Introduction: John Kulman is a renowned inventor hailing from Belmont, MA, known for his groundbreaking contributions to various fields of innovation.

Latest Patents: John Kulman holds several patents in the areas of renewable energy technologies, medical devices, and consumer electronics, showcasing his diverse range of expertise and creativity.

Career Highlights: With over two decades of experience in the industry, John Kulman has worked with leading research institutions and companies to develop cutting-edge solutions that have revolutionized their respective fields.

Collaborations: Throughout his career, John Kulman has collaborated with top universities, innovative startups, and established corporations, fostering a culture of innovation and excellence in all his projects.

Conclusion: John Kulman's passion for innovation and his relentless pursuit of excellence have solidified his reputation as a pioneering inventor, inspiring the next generation of innovators to push the boundaries of what is possible.

Profile summary based on public USPTO records.